Gary Rom

Gary Rom

Faegre Drinker Biddle & Reath LLP

Contact
View Bio
RSS

Latest Posts › BPCIA

Share:

FDA Issues Guidance for Applicants Seeking Biosimilar/Interchangeable Approval

The Food and Drug Administration (FDA) released new draft guidance, Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the BPCI Act, intended for prospective applicants of biologics...more

12/2/2020  /  Biosimilars , BPCIA , Draft Guidance , Food and Drug Administration (FDA) , Labeling , Licenses , Pharmaceutical Industry , Public Comment
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide